Histogen
Ms. Joyce Reyes is an executive with 20 years of Manufacturing, Regulatory Affairs and Quality Assurance experience in various roles at both small and large biotechnology or pharmaceutical companies. Ms. Reyes has extensive experience in small molecules, recombinant protein (fermentation and cell culture: monoclonal antibodies, enzymes, peptibodies, and biosimilars), cell/gene therapy and viral production processes, as well as auditing various CDMOs/CTLs/CROs. She also has partnership/collaborations with various QPs throughout Europe to conduct audits on their behalf.
Ms. Reyes formed Themis Quality and Regulatory Consulting, LLC in 2016. Prior to establishing Themis, she worked in various Quality, Regulatory Affairs, Supply Chain and CMC Project Management roles both as a consultant and full-time employee. Ms. Reyes received the degree of Bachelor of Arts from St. Mary’s College of California, Moraga and a Masters in Health Law from The University of California, San Diego/California Western School of Law. Ms. Reyes is also RAC certified.
This person is not in any offices
Histogen
Histogen is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.